title: Biotechnological drugs: the breakthrough in autoimmune rheumatic conditions.
authors.affiliation: Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Viale Golgi 2, 27100 Pavia, Italy.
authors.forename: Lorenzo
authors.identifier: 0000-0003-3292-1528
authors.initials: L
authors.lastname: Cavagna
authors.affiliation: Sections of Rheumatology and Pulmonary Medicine, Department of Medicine, Louisiana State University Health Sciences Center, 1542 Tulane Avenue, New Orleans, LA, USA.
authors.forename: Lesley-Ann
authors.initials: LA
authors.lastname: Saketkoo
authors.affiliation: Division of Rheumatology, Mainz University Hospital and ACURA Rheumatology Center, Kaiser-Wilhelm Street 9-11, Rhineland-Palatinate, 55543 Bad Kreuznach, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Schwarting
authors.affiliation: Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Viale Golgi 2, 27100 Pavia, Italy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Caporali
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology*; D015195:Drug Design; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents